SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 24*)
Sapiens International Corporation N.V.
(Name of Issuer)
Common Shares, € 0.01 par value
(Title of Class of Securities)
N7716A102
(CUSIP Number)
Guy Bernstein
Formula Systems (1985) Ltd.
5 Haplada St.
Or-Yehuda 60218, Israel
972-3-5389487
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
December 26, 2014
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. ¨
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP NO. N7716A102 | ||||
1. | Names of Reporting Persons | |||
Formula Systems (1985) Ltd. | ||||
2. |
Check the Appropriate Box if a Member of a Group (See Instructions) | |||
(a) | ¨ | |||
(b) | ¨ | |||
3. |
SEC USE ONLY
| |||
4. |
Source of funds (See Instructions)
WC | |||
5. | Check if disclosure of Legal Proceedings Is Required ¨ Pursuant to Items 2(d) or 2(e) | |||
6. |
Citizenship or Place of Organization
Israel | |||
Number of Shares Beneficially Owned by Each Reporting Person With |
7. |
Sole Voting Power 23,914,837 | ||
8. |
Shared Voting Power 0 | |||
9. |
Sole Dispositive Power 23,914,837 | |||
10. |
Shared Dispositive Power 0 | |||
11. |
Aggregate Amount Beneficially Owned by Each Reporting Person 23,914,837 | |||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions) ¨ | |||
13. |
Percent of Class Represented by Amount in Row(11) 50.2% | |||
14. |
Type of Reporting Person (See Instructions) CO | |||
Item1. Security and Issuer.
This Amendment No. 24 (this “Amendment”) to the Statement of Beneficial Ownership on Schedule 13D (the “Statement”) filed by the Reporting Person (as defined in Item 2 below) relates to the common shares, par value € 0.01 (“Common Shares”) of Sapiens International Corporation N.V. (“Sapiens” or the “Issuer”).
The Issuer is a Curaçao company, whose principal executive offices are located at Landhuis Joonchi; Kaya Richard J. Beaujon z/n; P.O. Box 837 Willemstad, Curaçao.
This Amendment is being filed by the Reporting Person to report an increase in its beneficial ownership of the Issuer’s Common Shares by in excess of one percent (1%) of the outstanding Common Shares since it filed Amendment No. 23 to the Statement. From September 17, 2014 (the day immediately following the day on which the Reporting Person filed Amendment No. 23 to the Statement) through December 26, 2014, the Reporting Person purchased an aggregate of 808,940 Common Shares in broker-initiated and private transactions, for an aggregate purchase price of $6,147,718.
Item 2: Identity and Background
The name of the reporting person is Formula Systems (1985) Ltd. (“Formula” or the “Reporting Person”), which is organized under the laws of the State of Israel.
Formula’s principal business is holding and managing interests in companies that provide global IT solutions and services.
Formula’s principal office is located at 5 Haplada St., Or-Yehuda, 60218, Israel.
There are no criminal convictions or civil judgments or injunctions to report under Item 2(d) or (e) of Schedule 13D.
Item 3: Source and Amount of Funds or Other Consideration
The source of funds for Formula’s purchases of Common Shares reported herein was Formula’s working capital.
Item 4: Purpose of Transaction
The Reporting Person has acquired the Common Shares of Sapiens for long-term investment purposes.
The Reporting Person may from time to time acquire additional Common Shares in the public market or in privately negotiated transactions in order to support its control position in Sapiens.
The Reporting Person does not have any current plans to dispose of securities of the Issuer or to effect any other transaction or change involving the Issuer that is described in Items 4(b) through (j) of Schedule 13D.
Item 5: Interest in Securities of the Issuer
(a), (b) Formula is the beneficial owner of and possesses sole voting and dispositive power with respect to 23,914,837 Common Shares, which represent 50.2% of the total issued and outstanding Common Shares of the Issuer. This percentage of beneficial ownership was calculated on the basis of 47,678,145 outstanding Common Shares of the Issuer as of December 26, 2014, which is based on information provided to the Reporting Person by the Issuer in response to the inquiry of the Reporting Person.
(c) During the past sixty days, Formula purchased Common Shares in the following transactions.
Date | Number of Shares Purchased | Price per Share | Nature of Transaction | |||
November 24, 2014 | 13,583 | $7.4364 | broker-initiated transaction consummated off-market | |||
November 25, 2014 | 17,197 | $7.4522 | broker-initiated transaction consummated off-market | |||
November 26, 2014 | 7,277 | $7.5496 | broker-initiated transaction consummated off-market | |||
November 28, 2014 | 4,833 | $7.5708 | broker-initiated transaction consummated off-market | |||
December 1, 2014 | 4,452 | $7.5998 | broker-initiated transaction consummated off-market | |||
December 2, 2014 | 300 | $7.6000 | broker-initiated transaction consummated off-market | |||
December 8, 2014 | 152,275 | $7.5616 | broker-initiated transaction consummated off-market | |||
December 9, 2014 | 37,921 | $7.5528 | broker-initiated transaction consummated off-market | |||
December 11, 2014 | 10,319 | $7.3501 | broker-initiated transaction consummated off-market | |||
December 18, 2014 | 5,200 | $7.3451 | broker-initiated transaction consummated off-market | |||
December 22, 2014 | 5,922 | $7.3421 | broker-initiated transaction consummated off-market | |||
December 23, 2014 | 400,000 | $7.5115 | off-market purchase | |||
December 24, 2014 | 300 | $7.3500 | broker-initiated transaction consummated off-market | |||
December 26, 2014 | 662 | $7.3100 | broker-initiated transaction consummated off-market |
(d) None.
(e) Not applicable.
Item 6: Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. |
None.
Item 7: Material to Be Filed as Exhibits
None.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: December 31, 2014
FORMULA SYSTEMS (1985) LTD.
By: /s/ Asaf Berenstin | |
Name: Asaf Berenstin |
Title: Chief Financial Officer